These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11129674)

  • 1. Restenosis and progression of coronary disease after balloon angioplasty in patients with diabetes mellitus.
    Rozenman Y; Sapoznikov D; Gotsman MS
    Clin Cardiol; 2000 Dec; 23(12):890-4. PubMed ID: 11129674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation.
    Rozenman Y; Sapoznikov D; Mosseri M; Gilon D; Lotan C; Nassar H; Weiss AT; Hasin Y; Gotsman MS
    J Am Coll Cardiol; 1997 Nov; 30(6):1420-5. PubMed ID: 9362396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic patterns of restenosis after angioplasty of multiple coronary arteries.
    DiSciascio G; Cowley MJ; Vetrovec GW
    Am J Cardiol; 1986 Nov; 58(10):922-5. PubMed ID: 2946214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coronary angioplasty on the progression of coronary atherosclerosis.
    Rozenman Y; Gilon D; Welber S; Sapoznikov D; Lotan C; Mosseri M; Weiss T; Hasin Y; Gotsman MS
    Am J Cardiol; 1995 Dec; 76(16):1126-30. PubMed ID: 7484896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.
    Van Belle E; Bauters C; Hubert E; Bodart JC; Abolmaali K; Meurice T; McFadden EP; Lablanche JM; Bertrand ME
    Circulation; 1997 Sep; 96(5):1454-60. PubMed ID: 9315531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcome after stenting for de novo versus restenotic narrowings in native coronary arteries.
    Mittal S; Weiss DL; Hirshfeld JW; Kolansky DM; Herrmann HC
    Am J Cardiol; 1997 Sep; 80(6):711-5. PubMed ID: 9315574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic deterioration of target coronary artery narrowing as a result of percutaneous balloon angioplasty.
    Rozenman Y; Gilon D; Sapoznikov D; Lotan C; Mosseri M; Hasin Y; Gotsman MS
    Am Heart J; 1997 May; 133(5):575-9. PubMed ID: 9141380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year angiographic outcome in patients without restenosis following coronary balloon angioplasty: a comparison between non diabetic and diabetic lesions.
    Takenaka S; Nakamura N; Shiode N; Shirota K; Suyama H; Goto Y; Hirao H; Nakazawa Y; Inoue K; Nagamatsu T
    Jpn Heart J; 2003 Jan; 44(1):31-9. PubMed ID: 12622435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty.
    Guiteras-Val P; Varas-Lorenzo C; Garcia-Picart J; Martí-Claramunt V; Augé-Sanpera JM
    Am J Cardiol; 1999 Mar; 83(6):868-74. PubMed ID: 10190401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus.
    Mazeika P; Prasad N; Bui S; Seidelin PH
    Am Heart J; 2003 Jun; 145(6):1013-21. PubMed ID: 12796757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study.
    Schofer J; Schlüter M; Rau T; Hammer F; Haag N; Mathey DG
    J Am Coll Cardiol; 2000 May; 35(6):1554-9. PubMed ID: 10807460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).
    Berger PB; Holmes DR; Ohman EM; O'Hanesian MA; Murphy JG; Schwartz RS; Serruys PW; Faxon DP
    J Am Coll Cardiol; 1996 Jan; 27(1):1-7. PubMed ID: 8522681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Rensing BJ; Foley DP; Deckers JW; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Am Coll Cardiol; 1992 Oct; 20(4):767-80. PubMed ID: 1388181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation.
    Abizaid A; Kornowski R; Mintz GS; Hong MK; Abizaid AS; Mehran R; Pichard AD; Kent KM; Satler LF; Wu H; Popma JJ; Leon MB
    J Am Coll Cardiol; 1998 Sep; 32(3):584-9. PubMed ID: 9741497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of the clinical and angiographic evolution of diabetic and nondiabetic patients treated by conventional angioplasty versus stent implantation in native coronary arteries].
    Navarro del Amo LF; Iñiguez Romo A; Ibargollín Hernández R; García Belenguer R; Fernández Rozas I; Rodríguez Carreras RC
    Rev Esp Cardiol; 2000 Feb; 53(2):172-8. PubMed ID: 10734748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.